Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.
Clinical trial NCT07041190 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07041190
- Sponsor
- PENTA Foundation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-11-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.